Skip to main content

Table 2 KRAS mutations and copy number variations observed in 18 of the 37 patients

From: KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver

Case #

KRAS gene alteration and location

2

G13D (c.38G > A) exon 2

5

G12D (c.35G > A) exon 2

6

A146T (c.436G > A) exon 4

7

G12A (c.35G > C) exon 2

8

G12D (c.35G > A) exon 2

9

Whole gene amplification 12p12.1, FC:2.1

11

Q61H (c. 183A > C) exon 3

14

G13D (c.38G > A) exon 2

15

G12V (c.35G > T) exon 2

16

G12D (c.35G > A) exon 2

23

G12D (c.35G > A) exon 2

24

G13D (c.38G > A) exon 2

25

G12D (c.35G > A) exon 2

28

Whole gene amplification 12p12.1, FC: 23.0 (Inv. Panel)

31

Q61H (c.183A > T) exon 3

32

G13D (c.38G > A) exon 2

35

G12C (c.34 G > T) exon 2

37

Whole gene amplification 12p12.1, FC: 8.5

  1. FC, fold change; Inv. Panel, investigational panel